COVID-19 Funding Opportunities

These are funding opportunities available to medical researchers specific to the Coronavirus Disease (COVID-19). 

Organization(s) Title Notice Number Expiration Date Activity Code(s)
NIMH Notice of Special Interest: Administrative Supplements for COVID-19 Impacted NIMH Research NOT-MH-21-120 6/2/2023 333
NIAMS Notice of Special Interest (NOSI): Promoting Research on COVID-19 and Rheumatic, Musculoskeletal and Skin Diseases NOT-AR-23-008 1/8/2024 R01, R21
NIAAA Notice of Special Interest: Research on Alcohol and Coronavirus Disease (COVID-19) within the Mission of NIAAA NOT-AA-22-012 3/6/2024 R01, R03, R21, K99/R00
NICHD, NIAAA, NIDA, NINDS, OBSSR, ORWH Notice of Special Interest (NOSI) – Administrative Supplements for Research of Emerging and Existing Issues of COVID-19 Related to the Health and Well-Being of Women, Children and Individuals with Physical and/or Intellectual Disabilities NOT-HD-22-003 6/6/2024 333
NICHD, NIDA, NIEHS, NINDS, OBSSR, ORWH Notice of Special Interest (NOSI) – Emerging and Existing Issues of Coronavirus Disease 2019 (COVID-19) Research Related to the Health and Well-Being of Women, Children and Individuals with Physical and/or Intellectual Disabilities NOT-HD-22-002 6/6/2024 R01, R21
NCATS, NIAMS, NICHD, NIDCR, NIGMS, NIMHD, OBSSR, ORWH Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional) PAR-22-167 10/18/2024 UG3/UH3
NIMH, NIAAA, NIEHS, ORWH Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R21-Clinical Trial Not Allowed) PAR-22-138 5/8/2025 R21
NIMH, NIAAA, NIEHS, ORWH Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R01-Clinical Trial Not Allowed) PAR-22-137 5/8/2025 R01
NHLBI Notice of Special Interest (NOSI): Enhancing Research on Deciphering Mechanisms of COVID-19-Associated Coagulopathy NOT-HL-23-080 7/6/2025 R01
NIH, NCATS, NCCIH, NCI, NHGRI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDCD, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINR, NLM, ORWH, OSC Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement – Clinical Trial Optional) PA-20-135 9/8/2025 333
NIDA, NCCIH, NIA, NIAAA Notice of Special Interest (NOSI) HEAL Initiative: Workforce Interventions to Improve Addiction Care Quality and Patient Outcomes NOT-DA-23-008 9/8/2025 R61/R33
NHLBI Notice of Special Interest (NOSI): Studies of Cellular/Molecular Pathobiological Mechanisms of Lung Diseases Using Human 3-Dimensional Cellular Systems (R01) NOT-HL-22-030 9/8/2025 R01
NIA Notice of Special Interest (NOSI): Neurological and Neurocognitive Sequelae from SARS-CoV-2 Infection and COVID-19 in Aging and Age-Related Neurodegeneration NOT-AG-21-016 05/08/23 R01, R21, R03
NIDCR Notice of Special Interest (NOSI): NIDCR Support for Research on the Physiological Involvement of Oral Cavity in Coronavirus Disease 2019 (COVID-19) NOT-DE-21-001 05/08/23 R01, R21
NIMHD, NCI, NIDA, NLM, ODP, OBSSR, NIMH, NIAMS Notice of Special Interest (NOSI): Simulation Modeling and Systems Science to Address Health Disparities NOT-MD-20-025 05/08/23 R01
NIMH Notice of Special Interest: Administrative Supplements for COVID-19 Impacted NIMH Research NOT-MH-21-120 06/02/23 333
NEI Notice of Special Interest (NOSI): Addressing Accessibility Inequities with COVID Home-Based Testing for Individuals with Visual Impairment NOT-EY-22-010 03/09/24 R41/R42, R15, 333, R01, R43/R44, R21
NIAAA Notice of Special Interest: Administrative Supplements and Urgent Competitive Revisions on Coronavirus Disease 2019 (COVID-19) within the Mission of NIAAA NOT-AA-22-002 05/08/24 333
NICHD Notice of Special Interest (NOSI): Promoting Vaccine Access, Acceptance and Uptake among Children, Adolescents, Pregnant and Lactating Women, and Persons with Disabilities NOT-HD-21-038 05/08/24 R03, R21
NIAID, NIMH, NIDA Notice of Special Interest (NOSI) HIV/AIDS in the Era of COVID-19: When Pandemics Collide NOT-AI-21-057 05/08/24 R01, R21
NHLBI Notice of Special Interest (NOSI): The Influence of Host Resilience on Heterogeneity of Acute Respiratory Distress Syndrome/Acute Lung Injury (ARDS/ALI) NOT-HL-20-814 07/06/24 R01
NCATS Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for the Clinical and Translational Science Award (CTSA) Program to Address COVID-19 Public Health Needs NOT-TR-21-022 08/17/24 333
NCATS Notice of Special Interest (NOSI): Administrative Supplements for the Clinical and Translational Science Award (CTSA) Program to Address COVID-19 Public Health Needs NOT-TR-21-017 08/17/24 333
NIDA Notice of Special Interest (NOSI): Telehealth Strategies for Individuals with HIV and Substance Use Disorders NOT-DA-21-019 09/08/24 R01, R03, R21
NIDA Notice of Special Interest (NOSI): Medical Consequences of Smoking and Vaping Drugs of Abuse in Individuals with HIV and COVID-19 NOT-DA-21-017 09/08/24 R01, R03, R21
NIDA Notice of Special Interest (NOSI): Long-Term Neurocognitive Consequences of COVID-19 in Individuals Living with HIV and Substance Use Disorders NOT-DA-21-018 09/08/24 R01, R03, R21
NIDA Notice of Special Interest (NOSI): Effects of smoking and vaping on the risk and outcome of COVID-19 infection NOT-DA-21-011 09/08/24 R01, R03, R21
NIDA RESCINDED – Notice of Special Interest (NOSI): Effects of smoking and vaping on the risk and outcome of COVID-19 infection NOT-DA-20-084 09/08/24 R01, R03, R21
NIMH Notice of Special Interest (NOSI): COVID-19 Pandemic Mental Health Research NOT-MH-22-100 01/08/25 R21, R34, R01
NHLBI Notice of Special Interest (NOSI): Research on barriers to care and risk of HIV-associated comorbidities among vulnerable population groups NOT-HL-22-010 05/08/25 R01
NHLBI, NICHD, NIAID Notice of Special Interest (NOSI) Pediatric COVID-19 and Respiratory Viral Co-infection NOT-HL-22-004 09/08/25 R01, R21
NIH, NCATS, NCCIH, NCI, NHGRI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDCD, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINR, NLM, ORWH, OSC Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement – Clinical Trial Optional) PA-20-135 09/08/25 333
Office of Biomedical Advanced Research and Development Authority (BARDA)  ǀ Broad Agency Announcement (BAA) BARDA expanded its standard broad agency announcement (BAA) to accept proposals for advanced development of diagnostics, vaccines, therapeutics and other medical products for use in the current COVID-19 emergency response and future coronavirus outbreaks.
National Science Foundation (NSF) (NSF) NSF Rapid Response Research (RAPID) funding mechanism for non-medical, non-clinical-care research that can be used immediately to explore how to model and understand the spread of COVID-19, to inform and educate about the science of virus transmission and prevention, and to encourage the development of processes and actions to address this global challenge.

◄ Back to Research website.

BACK TO TOP↑